Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin for liver fibrosis in alcohol-related advanced fibrosis
2020-006023-33Phase 2Active
- Sponsor
- August Pi i Sunyer Biomedical Research Institute
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in alcoholic liver disease (ALD) and hepatic fibrosis comparing Simvastatin with Placebo (2 arms). Primary endpoint: Histologic improvement in liver fibrosis. Started Jun 2021; status: active.
02
Drugs
simvastatin
03
Conditions
alcoholic liver disease (ALD)hepatic fibrosis
Beyond the preview
Go deeper on 2020-006023-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-006023-33.